A Study of LY3502970 in Participants With Impaired and Normal Liver Function

NCT05882032 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Hepatic Insufficiency

Interventions

DRUG: LY3502970

Sponsor

Eli Lilly and Company